Literature DB >> 18768485

Linking tobacco control policies and practices to early cancer endpoints: surveillance as an agent for change.

Anne M Hartman1, Michael J Thun, Rachel Ballard-Barbash.   

Abstract

State tobacco control programs provide an important laboratory for the development, implementation, and evaluation of comprehensive tobacco control interventions. Studies have shown that states and municipalities with aggressive tobacco control programs have experienced more rapid decreases in per capita cigarette sales, smoking prevalence, lung cancer, and heart disease than entities without such programs. Despite strong evidence that population-level interventions are critical in achieving large and sustained reductions in tobacco use, states do not fund tobacco control efforts at levels recommended by the Centers for Disease Control and Prevention. Research on the effectiveness and cost effectiveness of these activities is essential to inform and strengthen tobacco control at the state level. A workshop, co-organized by the American Cancer Society, the National Cancer Institute, the American Association for Cancer Research, and the Centers for Disease Control and Prevention, was held in Philadelphia in December, 2007, to discuss the topic "Linking tobacco control policies and practices to early cancer endpoints: surveillance as an agent for change." Participants represented three different disciplines. Tobacco surveillance researchers described the data currently collected on state-level tobacco control policies, protobacco countermeasures by the industry, public attitudes toward tobacco use, and measures of smoking prevalence and consumption. Cancer registry experts described the geographic coverage of high quality, population-based cancer registries. Mathematical modeling experts discussed various modeling approaches that can be used to relate upstream tobacco promotion and control activities to downstream measures such as public attitudes, changes in tobacco use, and trends in tobacco-related diseases. The most important recommendation of the Workshop was a call for national leadership to enhance the collection and integration of data from multiple sources as a resource to further study and strengthen the scientific basis for tobacco control.

Entities:  

Mesh:

Year:  2008        PMID: 18768485      PMCID: PMC2768308          DOI: 10.1158/1055-9965.EPI-08-0563

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  12 in total

1.  State variation in retail promotions and advertising for Marlboro cigarettes.

Authors:  S Slater; F J Chaloupka; M Wakefield
Journal:  Tob Control       Date:  2001-12       Impact factor: 7.552

Review 2.  Smoking in the movies increases adolescent smoking: a review.

Authors:  Annemarie Charlesworth; Stanton A Glantz
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

3.  Simulation modeling and tobacco control: creating more robust public health policies.

Authors:  David T Levy; Joseph E Bauer; Hye-Ryeon Lee
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

Review 4.  Monitoring the tobacco use epidemic I. Overview: Optimizing measurement to facilitate change.

Authors:  Gary A Giovino; Lois Biener; Anne M Hartman; Stephen E Marcus; Michael W Schooley; Terry F Pechacek; Donna Vallone
Journal:  Prev Med       Date:  2008-09-09       Impact factor: 4.018

5.  The California Tobacco Control Program's effect on adult smokers: (1) Smoking cessation.

Authors:  Karen Messer; John P Pierce; Shu-Hong Zhu; Anne M Hartman; Wael K Al-Delaimy; Dennis R Trinidad; Elizabeth A Gilpin
Journal:  Tob Control       Date:  2007-04       Impact factor: 7.552

6.  Multistage carcinogenesis and lung cancer mortality in three cohorts.

Authors:  William D Hazelton; Mark S Clements; Suresh H Moolgavkar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-05       Impact factor: 4.254

Review 7.  The tobacco epidemic in the United States.

Authors:  Gary A Giovino
Journal:  Am J Prev Med       Date:  2007-12       Impact factor: 5.043

8.  Evaluation of the American Stop Smoking Intervention Study (ASSIST): a report of outcomes.

Authors:  Frances A Stillman; Anne M Hartman; Barry I Graubard; Elizabeth A Gilpin; David M Murray; James T Gibson
Journal:  J Natl Cancer Inst       Date:  2003-11-19       Impact factor: 13.506

9.  Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control.

Authors:  Ahmedin Jemal; Michael J Thun; Lynn A G Ries; Holly L Howe; Hannah K Weir; Melissa M Center; Elizabeth Ward; Xiao-Cheng Wu; Christie Eheman; Robert Anderson; Umed A Ajani; Betsy Kohler; Brenda K Edwards
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

10.  Modeling the local dynamics of cardiovascular health: risk factors, context, and capacity.

Authors:  Jack Homer; Bobby Milstein; Kristina Wile; Parakash Pratibhu; Rosanne Farris; Diane R Orenstein
Journal:  Prev Chronic Dis       Date:  2008-03-15       Impact factor: 2.830

View more
  3 in total

1.  Capture of tobacco use among population-based registries: Findings from 10 National Program of Cancer Registries states.

Authors:  David A Siegel; S Jane Henley; Jennifer M Wike; A Blythe Ryerson; Christopher J Johnson; Judy R Rees; Lori A Pollack
Journal:  Cancer       Date:  2018-03-26       Impact factor: 6.860

Review 2.  Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.

Authors:  Richard J O'Connor; K Michael Cummings; Vaughan W Rees; Gregory N Connolly; Kaila J Norton; David Sweanor; Mark Parascandola; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

3.  Using a cessation-related outcome index to assess California's cessation progress at the population level.

Authors:  Hao Tang; Erin Abramsohn; Hye-Youn Park; David W Cowling; Wael K Al-Delaimy
Journal:  Tob Control       Date:  2010-04       Impact factor: 7.552

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.